Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 15 Jun 2026 for Biocryst Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleAmy E. McKee
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Amy E. McKee: trading record in brief
All filings by Amy E. McKee on record concern Biocryst Pharmaceuticals Inc, in the capacity of board member. In total, 10 filings cover trades dated from 7 June 2022 to 11 June 2026.
No open-market purchase appears, only 1 sale worth €51k. The rest of the record consists of 9 share grants.
The record was last updated on 15 June 2026 with a share grant in Biocryst Pharmaceuticals Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Amy E. McKee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
15,294 sharesCommon StockSEC:0000882796-26-000037:0
631 shares@ US$8.910.0002% mcap8.0% of flowCommon StockSEC:0000882796-26-000029:0
642 shares@ US$8.756.8% of flowCommon StockSEC:0000882796-26-000005:0
783 shares@ US$7.188.0% of flowCommon StockSEC:0000882796-25-000023:0
676 shares@ US$8.317.4% of flowCommon StockSEC:0000882796-25-000013:0
12,500 shares0Common StockSEC:0001171843-25-003916:0
8,600 shares@ US$6.3283.9% of flowCommon StockSEC:0001127602-24-019215:0
6,820 shares0Common StockSEC:0001127602-24-018728:0
16,745 shares0Common StockSEC:0001127602-23-018771:0
12,866 shares0Common StockSEC:0001127602-22-017160:0
10 of 10 declarations
